Correlation Between Nemaura Medical and Biomerica
Can any of the company-specific risk be diversified away by investing in both Nemaura Medical and Biomerica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nemaura Medical and Biomerica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nemaura Medical and Biomerica, you can compare the effects of market volatilities on Nemaura Medical and Biomerica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nemaura Medical with a short position of Biomerica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nemaura Medical and Biomerica.
Diversification Opportunities for Nemaura Medical and Biomerica
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Nemaura and Biomerica is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Nemaura Medical and Biomerica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomerica and Nemaura Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nemaura Medical are associated (or correlated) with Biomerica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomerica has no effect on the direction of Nemaura Medical i.e., Nemaura Medical and Biomerica go up and down completely randomly.
Pair Corralation between Nemaura Medical and Biomerica
If you would invest 93.00 in Nemaura Medical on September 23, 2024 and sell it today you would earn a total of 0.00 from holding Nemaura Medical or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
Nemaura Medical vs. Biomerica
Performance |
Timeline |
Nemaura Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Biomerica |
Nemaura Medical and Biomerica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nemaura Medical and Biomerica
The main advantage of trading using opposite Nemaura Medical and Biomerica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nemaura Medical position performs unexpectedly, Biomerica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomerica will offset losses from the drop in Biomerica's long position.Nemaura Medical vs. Neuropace | Nemaura Medical vs. CVRx Inc | Nemaura Medical vs. Orthofix Medical | Nemaura Medical vs. Artivion |
Biomerica vs. SurModics | Biomerica vs. Movano Inc | Biomerica vs. Ainos Inc | Biomerica vs. Tivic Health Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |